The relationship between serum sVCAM-1 and plasma von Willebrand factor (vWF) or thrombomodulin (TM) in diabetics

被引：0
|
作者：
Yoshizawa, M [1 ]
Nagai, Y [1 ]
Hisada, A [1 ]
Yamashita, H [1 ]
Ohta, M [1 ]
Kobayashi, K [1 ]
机构：
[1] KANAZAWA UNIV,SCH MED,DEPT INTERNAL MED 1,KANAZAWA,ISHIKAWA 920,JAPAN
来源：
DIABETOLOGIA | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1547 / 1547
页数：1
相关论文
共 50 条
  • [1] Comparison between plasma von Willebrand factor (VWF) and VWF antigen II level in normal individuals and patients with von Willebrand disease
    DeRomeuf, C
    Mazurier, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 640 - 640
  • [2] Quantitation of binding of Ricinus communis Agglutinin I to von Willebrand factor (VWF):: Investigation of relationship with plasma clearance of VWF in type 1 von Willebrand disease.
    Millar, CM
    Riddell, AF
    Brown, SA
    BLOOD, 2005, 106 (11) : 215A - 216A
  • [3] Plasma levels of thrombomodulin, von Willebrand Factor, sP-selectin, sVCAM-1 and ED1-fibronectin do not identify patients with a history of thrombosis and/or presence of lupus anticoagulant in a SLE population
    Frijns, CJM
    de Groot, PG
    Derksen, RHWM
    Fijnheer, R
    THROMBOSIS AND HAEMOSTASIS, 1999, : 66 - 66
  • [4] Comparison between von Willebrand factor (vWF) and vWF antigen II in normal individuals and patients with von Willebrand disease
    de Romeuf, C
    Mazurier, C
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (01) : 37 - 41
  • [5] Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis
    Yilmaz, Vural Taner
    Dincer, Dinc
    Avci, Ali Berkant
    Cetinkaya, Ramazan
    EURASIAN JOURNAL OF MEDICINE, 2015, 47 (01): : 21 - 25
  • [6] PROTEOLYSIS OF VON-WILLEBRAND-FACTOR (VWF) IN THERAPEUTIC PLASMA CONCENTRATES
    LATTUADA, A
    MANNUCCI, PM
    FEDERICI, AB
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1183 - 1183
  • [7] Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
    Haberichter, Sandra L.
    Balistreri, Michael
    Christopherson, Pamela
    Morateck, Patricia
    Gavazova, Stefana
    Bellissimo, Daniel B.
    Manco-Johnson, Marilyn J.
    Gill, Joan Cox
    Montgomery, Robert R.
    BLOOD, 2006, 108 (10) : 3344 - 3351
  • [8] Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor
    Aso, Y
    Fujiwara, Y
    Tayama, K
    Takanashi, K
    Inukai, T
    Takemura, Y
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 (04) : 210 - 216
  • [9] SPECIES SPECIFICITY OF REACTION BETWEEN PLATELETS AND PLASMA PLATELET AGGREGATING FACTOR (PAF) - VON WILLEBRAND FACTOR (VWF)
    BRINKHOUS, KM
    THOMAS, BD
    READ, MS
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 287 - 287
  • [10] PHARMACOKINETICS (PK) OF VON WILLEBRAND FACTOR (VWF) IN PATIENTS WITH VON WILLEBRAND DISEASE (VWD) AFTER TREATMENT WITH RECOMBINANT VWF OR PLASMA-DERIVED VWF CONCENTRATE.
    Wang, Y.
    Marier, J.
    Vasilinin, G.
    Berthoz, F. Truong
    Azen, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S36 - S37
12345